Member Info for roger65

Does 5 years count as 'impatience'? lol

Over £80k dumped in the last 3 hours. Mind you, compared with the volume that was happening last week that's nothing.

The silence is ominous and Gino needs to say something. If he doesn't then I think we've got bad news on the way...

What do you reckon has happened Guy?

I reckon Cheek had been hoodwinking the other Directors and Chairman saying sales had been lined up and when they expected announcements soon after the NICE announcement he had to come clean and say there aren't any and there won't be for the foreseeable future, or at best they would be bit by bit as and when any individual clinician can persuade his local NHS Trust to fork out the money for the machines, tests and staff training.

Such a shame. I think this latest fiasco will be the last straw for many

It does appear the new pilot test is in fact for the Lab testing capacity and not the use of GDR's machines or tests. This is a real blow and must be why Cheek has gone. GDR have achieved the NICE recommendation but it doesn't in any way force the NHS to buy a single machine or use any of the tests. Most clinicians will not be bothered to research and demand/ask for the GDR equipment to be installed and necessary staff trained to use it. They will simply stick with the status quo and re

'Bounce up coming...!!'

er...no, System.

The X post yesterday gave us a single sentence from Gino - and in fact that was from a previous communication rather than anything dated from his appointment: Genotype-guided drug prescribing is gaining pace in clinical practice, and our company is at the forefront of this globally in clinical paradigms where test result availability to clinicians is time critical.

This is a rehash of something stated in the annual reports and accounts released in Nov 2023.

So, even after what should have been transformational news at the end of last month Gino, even after he has been appointed the new CEO of the company, can't be bothered to release a single sentence to share holders. That's not just poor and lazy it's suspicious now. Any new CEO would say they are excited by the challenges that lie ahead, or something similar. Just seems as if Gino and GDR are in a spot of bother here. It's woeful that they have made no effort to garnish attention and make the most of that short window where the eyes of the market were on GDR. It ended up being simply an exercise for the day traders to have their fun.

WTF is going on behind the scenes. Take over or trouble at t'mill?? I'm now leaning towards the latter as no self respecting company Directors would utterly waste this opportunity to make hay whilst the sun shines. If there are any sales to be spoken of they are keen to keep silent about them. Why?

Ask now 3.20p and sinking

Talkinto - maybe you haven't been here long?

AIHL test kit gained NICE approval in March 2023. Since then sales have certainly proved to 'take some time to gain traction'. Many holders from that time said exactly the same, probably myself included, 'but once one sale is made I expect it will be a domino effect and also will result in repeat business'. Here we are nearly 18 months later and the sales of MT RNR1 have risen to approx £250k per year, have definitely NOT had the domino effect and don't even cover a single month of GDR's spending commitments. Can we expect the same from CYP2C19? I think so sadly. I will hold here for another few weeks but if come September there has been no announcement of sales contracts anywhere then that's the red line in the sand. I do fear that the Directors are not aligned with ordinary share holders here and even if the company was taken private they would be able to negotiate the means to make sure they weren't out of pocket. I seriously wonder if Cheek was against this route but that Gilham and Gino have already decided what's going to happen and that's what has caused the immediate departure of the former CEO.

This is starting to make me think something is afoot and not on a good way. The longer the silence goes on - and there was nothing new in the X post yesterday from GDR - the more I think it’s either the t remedy good news eg a takeover move or it’s bad news eg announcing it’s going to take longer than anticipated to generate income from sales (which we already know is the case now it’s been confirmed there will be NO National roll out within the NHS so sales are going to be piece- meal at best) and so they will be working on how to guarantee the company has enough capital to continue with the US clinical trials necessary for the FDA application for approval.

The company clearly didn’t have a single sales agreement lined up to announce NICE approval was gained. Given the time they had in advance to work on that is worrying in the extreme that something waffly like ‘gaining traction’ was used. That means there’s nothing meaningful eg £100k worth of sales as was announced not so long ago.

I hope for all our sakes Gino is working on selling the company or my prediction is it will be taken private as the funds start to run out in early 2025. There is no point developing great tests that only a handful of hospitals wants to buy or use .

Wow the PR department must have been busy this week coming up with all of that...

Actually there is one other prospect that no one has mentioned and might explain why Gino has not said a word as the news CEO…they’re taking it private

Could happen

Told you, silence is NEVER good for sentiment.

£100m market yes, How much do they currently have of that market..?? Let me tell you, about 0.25% ie £250k per year. Quite a way to go don't you think? Please ffs sell it to someone whilst the company has these approvals, some decent amount of cash in the bank and guarantee share holders a decent return. You are NOT an outfit that can possibly establish yourselves in a global market any time soon and I seriously worry you could blow this next phase and end up back where we were a few months ago ie still with little in the way of sales and no money in the bank and another looming dilution on the cards. For those not familiar with the GDR commercial team please do take a look at their achievements over the last 5 years.

I agree it's brilliant news. What isn't brilliant though is the fact they've known this news was due for months but only now appear to be starting the plan for commercialisation. I would prefer a bird in the hand via a company sale than two in the bush and be left hanging for another 2 or 3 years in the hope GDR's sales team can deliver for a change. I don't think they can and it would be best all round for a larger and established company with international sales already in place to take it on from here. I don't have faith in the team to realise GDR's potential. Simple as that. They have done incredibly well to gain approvals but Gino and Gilham should hand it on to one of the big players now and guarantee a good return for most share holders. The alternative is too grim to contemplate ie they go it alone and struggle with sales and end up coming back to do another placing in about 10 months time. With this lot no one can say that is out of the question.

NO word from Gino.

NO sales.

Sp will drift until sales are announced or an offer is tabled out of the blue. A company sale is Gilham's MO going on past experiences. I honestly think he will be surprised and disappointed in how long this has taken to come to fruition and is still a long way off gaining traction in sales and becoming a profitable company. I think Gilham would be happy to sell and that Gino is with him on this. Gino will be head of the new GDR division but within a much larger corporate entity. Just my view.

Highly unusual for a new CEO not to address share holders of any listed company on the first day or couple of days after their appointment.

Why can't he say anything? About to announce sales, or a sale of the company? Or just being kept busy on coming up with a long list of 'revenue opportunities' with the commercial team, as stated in the RNS. I rather hope they're actually doing some hand shaking on deals, whether that's to sell GDR machines and tests or indeed the whole shebang. Been here several years now waiting for just one person at GDR to pull their finger out with regard to sales but I don't think Gino as the new CEO is the answer to their perennial selling problem.

Come on, just tell us who is nibbling on the line and sniffing what's on offer....14.5p I'll bite your hand off!

Just did a dummy buy on HL for £5k and price offered was .3088

Not 33p

And it won’t be ‘rivals’ making a bid for GDR!

JB logs - is that a real Question? Just think for a second… Beckman Coulter, GlaxoSK, Astrazenica, Pfizer….. can they not sell products?? Jeez